EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia

Autor: Alabdulkarim, H, Almodaimegh, H, Abu Esba, LC, Sharma, Y, Attar, S, Hussain, W, Alhomood, I, Al-Omari, BA, Mohamed, O, Alsaqa’aby, M, Roshdy, A, Anwar, A, Hamad, T, Alzahrani, Z
Zdroj: In Value in Health July 2022 25(7) Supplement:S407-S407
Databáze: ScienceDirect
Externí odkaz: